不可复性牙髓炎的活髓保存治疗:生物学基础与临床进展

doi:10.13591/j.cnki.kqyx.2024.06.001

Abstract

Abstract:

Preserving the sustained vitality of dental pulp, maintaining the periapical tissues in a healthy state and implementing minimally invasive therapies are key themes within the development of contemporary endodontics. The research of irreversible pulpitis is of great importance within endodontics. The application and investigation of vital pulp therapy(VPT)in the field of irreversible pulpitis is expected to facilitate the precision and minimally invasive process in diagnosis and treatment of pulpitis. This review article focuses on the application of vital pulp therapy in the diagnosis and treatment of irreversible pulpitis as well as the challenges.

Key words: vital pulp therapy, irreversible pulpitis, pulpotomy, diagnosis, treatment

CLC Number:

R781.3

LIU Hongyan, ZHENG Siyi, WEI Xi. New advances in vital pulp therapy for the treatment of irreversible pulpitis: From biological basic to clinical perspective[J]. Stomatology, 2024, 44(6): 401-407.

Figures/Tables 1

References 61

[1]	AAE. AAE Consensus Conference recommended diagnostic terminology[J]. J Endod, 2009, 35(12):1634.
[2]	周学东. 牙体牙髓病学[M]. 5版. 北京: 人民卫生出版社, 2020: 163-164.
[3]	Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis[J]. Int Endod J, 2018, 51(8):819-828. doi: 10.1111/iej.12903 pmid: 29397003
[4]	Taha NA, Abdulkhader SZ. Full pulpotomy with biodentine in symptomatic young permanent teeth with carious exposure[J]. J Endod, 2018, 44(6):932-937. doi: S0099-2399(18)30165-1 pmid: 29681479
[5]	Uesrichai N, Nirunsittirat A, Chuveera P, et al. Partial pulpotomy with two bioactive cements in permanent teeth of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: A noninferiority randomized controlled trial[J]. Int Endod J, 2019, 52(6):749-759. doi: 10.1111/iej.13071 pmid: 30638262
[6]	Ramani A, Sangwan P, Tewari S, et al. Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: A randomized clinical trial[J]. Int Endod J, 2022, 55(5):430-440.
[7]	Tzanetakis GN, Papanakou S, Koletsi D, et al. Outcome of partial pulpotomy in immature permanent teeth with symptomatic irreversible pulpitis: A prospective case series assessment[J]. J Endod, 2023, 49(9):1120-1128.
[8]	Tzanetakis GN, Koletsi D, Georgopoulou M. Treatment outcome of partial pulpotomy using two different calcium silicate materials in mature permanent teeth with symptoms of irreversible pulpitis: A randomized clinical trial[J]. Int Endod J, 2023, 56(10):1178-1196.
[9]	Aldeen RZ, Aljabban O, Almanadili A, et al. The influence of carious lesion and bleeding time on the success of partial pulpotomy in permanent molars with irreversible pulpitis: A prospective study[J]. Bioengineering(Basel), 2023, 10(6):700.
[10]	Sheng M, Zhang DH, Yan J, et al. Relationship between time to hemostasis and outcomes of pulpotomy using iRoot BP Plus in symptomatic young permanent teeth: A prospective study[J]. J Clin Pediatr Dent, 2023, 47(6):142-149. doi: 10.22514/jocpd.2023.088 pmid: 37997245
[11]	Jassal A, Nawal RR, Yadav S, et al. Outcome of partial and full pulpotomy in cariously exposed mature molars with symptoms indicative of irreversible pulpitis: A randomized controlled trial[J]. Int Endod J, 2023, 56(3):331-344.
[12]	Taha NA, Abuzaid AM, Khader YS. A randomized controlled clinical trial of pulpotomy versus root canal therapy in mature teeth with irreversible pulpitis: Outcome, quality of life, and patients’ satisfaction[J]. J Endod, 2023, 49(6):624-631. e2.
[13]	Cushley S, Duncan HF, Lappin MJ, et al. Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: A systematic review[J]. J Dent, 2019, 88: 103158.
[14]	Jang JH, Shin HW, Lee JM, et al. An overview of pathogen recognition receptors for innate immunity in dental pulp[J]. Mediators Inflamm, 2015, 2015: 794143.
[15]	何文喜, 余擎. 牙髓炎的活髓保存及再生治疗新进展:从基础到临床[J]. 中华口腔医学杂志, 2022, 57(1):16-22.
[16]	Islam R, Islam MRR, Tanaka T, et al. Direct pulp capping procedures-evidence and practice[J]. Jpn Dent Sci Rev, 2023, 59: 48-61.
[17]	Lin LM, Ricucci D, Saoud TM, et al. Vital pulp therapy of mature permanent teeth with irreversible pulpitis from the perspective of pulp biology[J]. Aust Endod J, 2020, 46(1):154-166. doi: 10.1111/aej.12392 pmid: 31865629
[18]	Ricucci D, Loghin S, Lin LM, et al. Is hard tissue formation in the dental pulp after the death of the primary odontoblasts a regenerative or a reparative process?[J]. J Dent, 2014, 42(9):1156-1170. doi: 10.1016/j.jdent.2014.06.012 pmid: 25008021
[19]	Ricucci D, Loghin S, Jr Siqueira JF. Correlation between clinical and histologic pulp diagnoses[J]. J Endod, 2014, 40(12):1932-1939. doi: 10.1016/j.joen.2014.08.010 pmid: 25312886
[20]	Skitioui M, Seck A, Niang SO, et al. The treatment of mature permanent teeth with irreversible pulpitis by cervical pulpotomy: A systematic review[J]. Aust Endod J, 2023, 49(Suppl 1):488-493.
[21]	周学东, 黄定明, 刘建国, 等. 牙髓损伤的活髓保存治疗[J]. 华西口腔医学杂志, 2017, 35(4):339-347.
[22]	European Society of Endodontology developed by:, Duncan HF, Galler KM, et al. European Society of Endodontology position statement: Management of deep caries and the exposed pulp[J]. Int Endod J, 2019, 52(7):923-934. doi: 10.1111/iej.13080 pmid: 30664240
[23]	AAE. AAE position statement on vital pulp therapy[J]. J Endod, 2021, 47(9):1340-1344. doi: 10.1016/j.joen.2021.07.015 pmid: 34352305
[24]	Kahler B, Taha NA, Lu J, et al. Vital pulp therapy for permanent teeth with diagnosis of irreversible pulpitis: Biological basis and outcome[J]. Aust Dent J, 2023, 68(Suppl 1):S110-S122.
[25]	Santos JM, Pereira JF, Marques A, et al. Vital pulp therapy in permanent mature posterior teeth with symptomatic irreversible pulpitis: A systematic review of treatment outcomes[J]. Medicina(Kaunas), 2021, 57(6):573.
[26]	Ballal NV, Duncan HF, Rai N, et al. Sodium hypochlorite reduces postoperative discomfort and painful early failure after carious exposure and direct pulp capping-initial findings of a randomized controlled trial[J]. J Clin Med, 2020, 9(8):2408.
[27]	Sabeti M, Huang YJ, Chung YJ, et al. Prognosis of vital pulp therapy on permanent dentition: A systematic review and meta-analysis of randomized controlled trials[J]. J Endod, 2021, 47(11):1683-1695. doi: 10.1016/j.joen.2021.08.008 pmid: 34478787
[28]	Swetha D, Ballal S, Sundar S, et al. The outcome of GaAlAs diode laser(980 nm)pulpotomy in patients with symptomatic irreversible pulpitis assessed using CBCT-randomised controlled trial with an 18-month follow-up[J]. Eur Endod J, 2024, 9(1):35-43.
[29]	Ayhan M, Altunbaş D. Efficacy of potassium titanyl phosphate laser and sodium hypochlorite on postoperative pain intensity following pulpotomy in teeth with symptomatic irreversible pulpitis: A randomized clinical trial[J]. Photobiomodul Photomed Laser Surg, 2023, 41(5):225-233.
[30]	Duncan HF, Kirkevang LL, Peters OA, et al. Treatment of pulpal and apical disease: The European Society of Endodontology(ESE)S3-level clinical practice guideline[J]. Int Endod J, 2023, 56(Suppl 3):238-295.
[31]	Berman LH, Hargreaves KM. Cohen’s pathways of the pulp[M]. 12th ed. Amsterdam: Elsevier Health Sciences, 2020.
[32]	Linsuwanont P, Wimonsutthikul K, Pothimoke U, et al. Treatment outcomes of mineral trioxide aggregate pulpotomy in vital permanent teeth with carious pulp exposure: The retrospective study[J]. J Endod, 2017, 43(2):225-230. doi: S0099-2399(16)30754-3 pmid: 28041685
[33]	Reeves R, Stanley HR. The relationship of bacterial penetration and pulpal pathosis in carious teeth[J]. Oral Surg Oral Med Oral Pathol, 1966, 22(1):59-65.
[34]	Philip N, Suneja B. Minimally invasive endodontics: A new era for pulpotomy in mature permanent teeth[J]. Br Dent J, 2022, 233(12):1035-1041.
[35]	Mutluay M, Arıkan V, Sarı S, et al. Does achievement of hemostasis after pulp exposure provide an accurate assessment of pulp inflammation?[J]. Pediatr Dent, 2018, 40(1):37-42. pmid: 29482681
[36]	汪俊. 不可复性牙髓炎恒牙的活髓保存治疗[J]. 华西口腔医学杂志, 2023, 41(6):622-627.
[37]	Parirokh M, Torabinejad M, Dummer PMH. Mineral trioxide aggregate and other bioactive endodontic cements: An updated overview-part Ⅰ: Vital pulp therapy[J]. Int Endod J, 2018, 51(2):177-205. doi: 10.1111/iej.12841 pmid: 28836288
[38]	Duncan HF, El-Karim I, Dummer PMH, et al. Factors that influence the outcome of pulpotomy in permanent teeth[J]. Int Endod J, 2023, 56(Suppl 2):62-81.
[39]	Al-Asmar AA, Al-Hiyasat AS, Abu-Awwad M, et al. Reframing perceptions in restorative dentistry: Evidence-based dentistry and clinical decision-making[J]. Int J Dent, 2021, 2021: 4871385.
[40]	Alfaisal Y, Idris G, Peters OA, et al. Vital pulp therapy-Factors influencing decision-making for permanent mature teeth with irreversible pulpitis: A systematic review[J]. Int Endod J, 2024, 57(5):505-519.
[41]	Li MJ, Hu XL, Li XL, et al. Dentist-related factors influencing the use of vital pulp therapy: A survey among dental practitioners in China[J]. J Int Med Res, 2019, 47(6):2381-2393. doi: 10.1177/0300060519843406 pmid: 30991868
[42]	Wolters WJ, Duncan HF, Tomson PL, et al. Minimally invasive endodontics: A new diagnostic system for assessing pulpitis and subsequent treatment needs[J]. Int Endod J, 2017, 50(9):825-829. doi: 10.1111/iej.12793 pmid: 28776717
[43]	Hashem D, Mannocci F, Patel S, et al. Clinical and radiographic assessment of the efficacy of calcium silicate indirect pulp capping: A randomized controlled clinical trial[J]. J Dent Res, 2015, 94(4):562-568. doi: 10.1177/0022034515571415 pmid: 25710953
[44]	Careddu R, Duncan HF. A prospective clinical study investigating the effectiveness of partial pulpotomy after relating preoperative symptoms to a new and established classification of pulpitis[J]. Int Endod J, 2021, 54(12):2156-2172. doi: 10.1111/iej.13629 pmid: 34490637
[45]	Huang X, Chen K. Differential expression of longnoncoding RNAs in normal and inflamed human dental pulp[J]. J Endod, 2018, 44(1):62-72. doi: S0099-2399(17)30966-4 pmid: 29079059
[46]	Zhong S, Zhang SP, Bair E, et al. Differential expression of microRNAs in normal and inflamed human pulps[J]. J Endod, 2012, 38(6):746-752. doi: 10.1016/j.joen.2012.02.020 pmid: 22595106
[47]	Zanini M, Meyer E, Simon S. Pulp inflammation diagnosis from clinical to inflammatory mediators: A systematic review[J]. J Endod, 2017, 43(7):1033-1051. doi: S0099-2399(17)30249-2 pmid: 28527838
[48]	Golbasi F, Erdemir A, Kisa U. Comparison of ADAMTS levels in pulp tissue samples of healthy and symptomatic irreversible pulpitis teeth[J]. J Endod, 2022, 48(4):496-501.
[49]	Brizuela C, Meza G, Mercadé M, et al. Inflammatory biomarkers in dentinal fluid as an approach to molecular diagnostics in pulpitis[J]. Int Endod J, 2020, 53(9):1181-1191. doi: 10.1111/iej.13343 pmid: 32496605
[50]	Mente J, Petrovic J, Gehrig H, et al. A prospective clinical pilot study on the level of matrix metalloproteinase-9 in dental pulpal blood as a marker for the state of inflammation in the pulp tissue[J]. J Endod, 2016, 42(2):190-197. doi: 10.1016/j.joen.2015.10.020 pmid: 26725178
[51]	Sharma R, Kumar V, Logani A, et al. Association between concentration of active MMP-9 in pulpal blood and pulpotomy outcome in permanent mature teeth with irreversible pulpitis-a preliminary study[J]. Int Endod J, 2021, 54(4):479-489. doi: 10.1111/iej.13437 pmid: 33128238
[52]	Ballal NV, Duncan HF, Wiedemeier DB, et al. MMP-9 levels and NaOCl lavage in randomized trial on direct pulp capping[J]. J Dent Res, 2022, 101(4):414-419.
[53]	Ballal NV, Duncan HF, Wiedemeier DB, et al. 4-year pulp survival in a randomized trial on direct pulp capping[J]. J Endod, 2024, 50(1):4-9.
[54]	Li M, Tian J, Xu Z, et al. Histology-based profile of inflammatory mediators in experimentally induced pulpitis in a rat model: Screening for possible biomarkers[J]. Int Endod J, 2021, 54(8):1328-1341. doi: 10.1111/iej.13514 pmid: 33715185
[55]	Swanson WB, Gong T, Zhang Z, et al. Controlled release of odontogenic exosomes from a biodegradable vehicle mediates dentinogenesis as a novel biomimetic pulp capping therapy[J]. J Control Release, 2020, 324: 679-694.
[56]	Duncan HF, Kobayashi Y, Kearney M, et al. Epigenetic therapeutics in dental pulp treatment: Hopes, challenges and concerns for the development of next-generation biomaterials[J]. Bioact Mater, 2023, 27: 574-593. doi: 10.1016/j.bioactmat.2023.04.013 pmid: 37213443
[57]	Liu Z, Chen T, Han QQ, et al. HDAC inhibitor LMK-235 promotes the odontoblast differentiation of dental pulp cells[J]. Mol Med Rep, 2018, 17(1):1445-1452.
[58]	Zeng Q, Zhou C, Li MJ, et al. Concentrated growth factor combined with iRoot BP Plus promotes inflamed pulp repair: An in vitro and in vivo study[J]. BMC Oral Health, 2023, 23(1):225.
[59]	Qiu Y, Tian J, Kong SY, et al. SrCuSi₄O₁₀/GelMA composite hydrogel-mediated vital pulp therapy: Integrating antibacterial property and enhanced pulp regeneration activity[J]. Adv Healthc Mater, 2023, 12(24):e2300546.
[60]	郑颖, 陈雪姣, 王倩. 单向滤膜减压保髓新技术用于不可复性牙髓炎活髓保存治疗1例[J]. 中华口腔医学杂志, 2024, 59(1):85-88.
[61]	中共中央、国务院. “健康中国2030”规划纲要[EB/OL]. (2016-10-25)[2024-3-12]. https://www.gov.cn/zhengce/2016-10/25/content_5124174.htm.

New advances in vital pulp therapy for the treatment of irreversible pulpitis: From biological basic to clinical perspective

RichHTML

PDF (PC)

Supplement

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 61

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	LU Caixia, ZHANG Simin, Nigeayi·AIHEMAITI , LI Xueer, CHEN Zeyuan, Maimaitituxun·TUERDI . Effect of medical ozone injection therapy on temporomandibular joint osteoarthritis and its pain in rats [J]. Stomatology, 2024, 44(5): 362-368.
[2]	GUO Kai, HAN Xinying, MA Haojie, LIU Lijuan, YANG Fanghong. One case of double-stage orthodontic treatment of skeletal Class Ⅱ combined with impacted teeth [J]. Stomatology, 2024, 44(5): 338-343.
[3]	SONG Ye, REN Yinting, ZHANG Yihan, HAN Jingying. The effect of different tooth extraction patterns on Bolton index and occlusal relationship of skeletal Class Ⅱ malocclusion [J]. Stomatology, 2024, 44(5): 334-337.
[4]	TIAN Liangliang, ZHAO Jiaxiong, NAN Xinrong. Progress of research on the diagnosis and treatment of accessory parotid gland tumor [J]. Stomatology, 2024, 44(5): 397-400.
[5]	YAO Chengliang, WU Xiuping. Correlation between imaging measurements and diagnosis of adenoid hypertrophy and orthodontic treatment in adolescent children [J]. Stomatology, 2024, 44(4): 307-311.
[6]	WANG Xuekui, SUN Yao. Role of neutrophil in periodontitis: An updated review [J]. Stomatology, 2024, 44(4): 292-296.
[7]	TIAN Xin, WU Sihua, DAN Hongxia, ZENG Xin, WANG Jiongke, CHEN Qianming. New developments in the clinical presentation and diagnosis of granulomatosis with polyangiitis [J]. Stomatology, 2024, 44(3): 209-213.
[8]	LIU Mei, ZHANG Lei, PU Yumei, HUANG Xiaofeng, XU Wantian, SUN Guowen. Clinicopathological analysis of oral granular cell tumor [J]. Stomatology, 2024, 44(3): 168-172.
[9]	XIAO Shimeng, LIU Yi, LI Maoxue, DING Yi. Evaluation of the efficacy of laser-assisted non-surgical treatment of periodontitis with type 2 diabetes mellitus [J]. Stomatology, 2024, 44(3): 161-167.
[10]	FU Kaiyuan, LEI Jie. Update of the classification, diagnosis and management of temporomandibular disorders [J]. Stomatology, 2024, 44(1): 6-10.
[11]	LI Chengxi, SONG Weijian. Treatment of mandibular second molar with calcified root canals by dynamic navigation technology: A case report [J]. Stomatology, 2023, 43(9): 832-836.
[12]	YANG Zhenze, LIN Jun. Application and prospect of artificial intelligence in orthodontic and orthognathic combined treatment [J]. Stomatology, 2023, 43(8): 747-751.
[13]	HUANG Hong, LI Yuan, JING Qiuping, SHI Yijin, YANG Shengjun, WANG Dongmiao. Factors affecting the eruption status of mandibular third molars in adolescent orthodontic patients [J]. Stomatology, 2023, 43(8): 697-701.
[14]	ZHANG Kejia, SHI Xueming, HU Danyan, QIAN Xinyao, LIU Luwei, CAO Dan, YAN Bin. Analysis of contributing factors for gingivial black trangle after non-extraction orthodontic treatment of crowded mandibular anterior teeth [J]. Stomatology, 2023, 43(6): 518-523.
[15]	WU Bo,LIU Li,HUANG Chenjia,YU Yi. Effects of esketamine and sevoflurane on hemodynamics and recovery quality in children undergoing dental treatment under non-intubated anesthesia [J]. Stomatology, 2023, 43(5): 456-459.